Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.

18 patients with osteogenic sarcoma were followed by serial measurements in vitro of tumor-specific cell-mediated cytotoxicity and of "active" and total rosette-forming T-cells. 13 of these patients have had or are currently receiving injections of osteogenic sarcoma-specific dialyzable tr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Invest
Glavni autori: Levin, A S, Byers, V S, Fudenberg, H H, Wybran, J, Hackett, A J, Johnston, J O, Spitler, L E
Format: Artigo
Jezik:Inglês
Izdano: American Society for Clinical Investigation 1975
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC301776/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1078826/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI107955
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items